IRF9 Antikörper (AA 171-393)
Kurzübersicht für IRF9 Antikörper (AA 171-393) (ABIN1498905)
Target
Alle IRF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 171-393
-
Spezifität
- Human IRF9
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Bovine (84%) Mouse (81%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Recombinant fragment corresponding to a region within amino acids 171 and 393 of IRF9 (SwissProt Q00978). Percent identity by BLAST analysis: Human (100%), Bovine (84%), Mouse (81%).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ICC (1:100 - 1:1000), IF (1:100 - 1:1000), IHC, IHC-P (1:100 - 1:1000), WB (1:1000 - 1:10000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:1000-1:10000, IHC-Paraffin: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0)], ICC/IF: 1:100-1:1000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Andere Bezeichnung
- ISGF3 / IRF9
-
Hintergrund
-
Name/Gene ID: IRF9
Synonyms: IRF9, Interferon regulatory factor 9, ISGF3 p48 subunit, ISGF3G, p48, IRF-9, ISGF3, ISGF-3 gamma -
Gen-ID
- 10379
-
UniProt
- Q00978
-
Pathways
- JAK-STAT Signalweg, Interferon-gamma Pathway, Hepatitis C
Target
-